Comparative effectiveness of influenza vaccines in adults 65 years of age and older: a systematic review and network meta-analysis Commissioner: Public Health Agency of Canada (PHAC) Funder: Canadian Institutes of Health Research (CIHR) through the Drug Safety and Effectiveness Network (DSEN) Share Buttons [ssba-buttons] Impact for Knowledge UsersProtocol To provide information on which influenza vaccine available for adults 65 years of age or older is the most effective PROSPERO registration Protocol brief Conflict of Interest summary Related Projects: Influenza vaccines: cost-effectiveness in older adults Dose-sparing strategies for seasonal influenza vaccine Category : KS Projects Date : 15 Jan 2021 Complex Wounds: Effective Interventions (Prev Entry) (Next Entry) Influenza vaccines: cost-effectiveness in older adults